Mosapride, a serotonin 5-HT4 receptor agonist, and alogliptin, a selective dipeptidyl peptidase-4 inhibitor, exert additive effects on plasma active GLP=1 levels in mice

Mosapride, a serotonin 5-HT4 receptor agonist, and alogliptin, a selective dipeptidyl peptidase-4 inhibitor, exert additive effects on plasma active GLP=1 levels in mice
复制标题

莫沙必利(一种血清素 5-HT4 受体激动剂)和阿格列汀(一种选择性二肽基肽酶 4 抑制剂)对小鼠血浆活性 GLP=1 水平产生累加作用

DOI:
--
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Katsunori Nonogaki
Katsunori Nonogaki
中科院分区:
--
文献类型:
--
作者:
野々垣勝則;佐藤典子;Katsunori Nonogaki

文献摘要

相似文献